Therefore, together these findings first support the fact that in certain TNBCs when TET1 is high, immune response genes are low, and in other basal-like breast cancers, TET1 is low possibly because of immune system modulating the cancer cell epigenetics. The gene discussed is TET1; the disease is breast cancer.